Literature DB >> 19038345

Acetylcholinesterase as an amyloid enhancing factor in PrP82-146 aggregation process.

M Pera1, A Martínez-Otero, L Colombo, M Salmona, D Ruiz-Molina, A Badia, M V Clos.   

Abstract

Acetylcholinesterase (AChE) triggers beta amyloid plaques formation and is associated with amyloid plaques in the brain. Recent studies have demonstrated that AChE promotes the aggregation of PrP106-126, a peptide deduced from the prion protein sequence. In the present study we show that AChE triggers also the fibrillization of the main component of the amyloid plaques -the peptide spanning residues 82-146 (PrP82-146)- found in patients with Gerstmann-Sträussler-Scheinker disease (GSS). The kinetics of PrP82-146 aggregate formation was directly correlated with AChE concentration and mature fibrils showed the tinctorial and optical properties of amyloid. Atomic force microscopy analysis showed that oligomer and amyloid fibril formation were significantly accelerated by AChE. This effect was mediated by the peripheral site of the enzyme since propidium iodide inhibited the fibrillization process. Present results strongly support the role of AChE in triggering amyloidogenesis and the potential therapeutic relevance of peripheral site blocker compounds.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038345     DOI: 10.1016/j.mcn.2008.10.008

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  6 in total

1.  A Drosophila model of GSS syndrome suggests defects in active zones are responsible for pathogenesis of GSS syndrome.

Authors:  Jin-Kyu Choi; Yong-Chul Jeon; Dae-Weon Lee; Jae-Min Oh; Hyun-Pil Lee; Byung-Hoon Jeong; Richard I Carp; Young Ho Koh; Yong-Sun Kim
Journal:  Hum Mol Genet       Date:  2010-09-09       Impact factor: 6.150

Review 2.  Therapeutic strategies for identifying small molecules against prion diseases.

Authors:  Elisa Uliassi; Lea Nikolic; Maria Laura Bolognesi; Giuseppe Legname
Journal:  Cell Tissue Res       Date:  2022-01-06       Impact factor: 5.249

3.  Interactions of AChE with Aβ Aggregates in Alzheimer's Brain: Therapeutic Relevance of IDN 5706.

Authors:  Francisco J Carvajal; Nibaldo C Inestrosa
Journal:  Front Mol Neurosci       Date:  2011-09-14       Impact factor: 5.639

4.  Interaction of prion protein with acetylcholinesterase: potential pathobiological implications in prion diseases.

Authors:  Joan Torrent; Alba Vilchez-Acosta; Diego Muñoz-Torrero; Marie Trovaslet; Florian Nachon; Arnaud Chatonnet; Katarina Grznarova; Isabelle Acquatella-Tran Van Ba; Ronan Le Goffic; Laetitia Herzog; Vincent Béringue; Human Rezaei
Journal:  Acta Neuropathol Commun       Date:  2015-04-03       Impact factor: 7.801

5.  Design, synthesis, and bio-evaluation of new isoindoline-1,3-dione derivatives as possible inhibitors of acetylcholinesterase.

Authors:  Motahareh Hassanzadeh; Farshid Hassanzadeh; Ghadam Ali Khodarahmi; Mahbobe Rostami; Fateme Azimi; Hamid Nadri; Farshad Homayouni Moghadam
Journal:  Res Pharm Sci       Date:  2021-08-19

6.  Undifferentiated and differentiated PC12 cells protected by huprines against injury induced by hydrogen peroxide.

Authors:  Marta Pera; Pelayo Camps; Diego Muñoz-Torrero; Belen Perez; Albert Badia; M Victoria Clos Guillen
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.